1. Albaugh PA, Marshall L, Gregory J, White G, Hutchison A, Ross PC, Gallagher DW, Tallman JF, Crago M, Cassella JV. (2002) Synthesis and biological evaluation of 7,8,9,10-tetrahydroimidazo[1,2-c]pyrido[3,4-e]pyrimdin-5(6H)-ones as functionally selective ligands of the benzodiazepine receptor site on the GABA(A) receptor.
J Med Chem, 45 (23): 5043-51.
[PMID:12408715]
2. Arias AJ, Covault J, Feinn R, Pond T, Yang BZ, Ge W, Oncken C, Kranzler HR. (2014) A GABRA2 variant is associated with increased stimulation and 'high' following alcohol administration.
Alcohol Alcohol, 49 (1): 1-9.
[PMID:24166645]
3. AstraZeneca. AZD7325.
Accessed on 11/09/2014. Modified on 11/09/2014.
astrazeneca.com, http://openinnovation.astrazeneca.com/what-we-offer/compound/azd7325/
4. Bierut LJ, Agrawal A, Bucholz KK, Doheny KF, Laurie C, Pugh E, Fisher S, Fox L, Howells W, Bertelsen S et al.. (2010) A genome-wide association study of alcohol dependence.
Proc Natl Acad Sci USA, 107 (11): 5082-7.
[PMID:20202923]
5. Cox ED, Diaz-Arauzo H, Huang Q, Reddy MS, Ma C, Harris B, McKernan R, Skolnick P, Cook JM. (1998) Synthesis and evaluation of analogues of the partial agonist 6-(propyloxy)-4-(methoxymethyl)-beta-carboline-3-carboxylic acid ethyl ester (6-PBC) and the full agonist 6-(benzyloxy)-4-(methoxymethyl)-beta-carboline-3-carboxylic acid ethyl ester (Zk 93423) at wild type and recombinant GABAA receptors.
J Med Chem, 41 (14): 2537-52.
[PMID:9651158]
6. Hadingham KL, Garrett EM, Wafford KA, Bain C, Heavens RP, Sirinathsinghji DJ, Whiting PJ. (1996) Cloning of cDNAs encoding the human gamma-aminobutyric acid type A receptor alpha 6 subunit and characterization of the pharmacology of alpha 6-containing receptors.
Mol Pharmacol, 49 (2): 253-9.
[PMID:8632757]
7. Hadingham KL, Wingrove P, Le Bourdelles B, Palmer KJ, Ragan CI, Whiting PJ. (1993) Cloning of cDNA sequences encoding human alpha 2 and alpha 3 gamma-aminobutyric acidA receptor subunits and characterization of the benzodiazepine pharmacology of recombinant alpha 1-, alpha 2-, alpha 3-, and alpha 5-containing human gamma-aminobutyric acidA receptors.
Mol Pharmacol, 43 (6): 970-5.
[PMID:8391122]
8. Huang Q, He X, Ma C, Liu R, Yu S, Dayer CA, Wenger GR, McKernan R, Cook JM. (2000) Pharmacophore/receptor models for GABA(A)/BzR subtypes (alpha1beta3gamma2, alpha5beta3gamma2, and alpha6beta3gamma2) via a comprehensive ligand-mapping approach.
J Med Chem, 43 (1): 71-95.
[PMID:10633039]
9. Khrestchatisky M, MacLennan AJ, Tillakaratne NJ, Chiang MY, Tobin AJ. (1991) Sequence and regional distribution of the mRNA encoding the alpha 2 polypeptide of rat gamma-aminobutyric acidA receptors.
J Neurochem, 56 (5): 1717-22.
[PMID:1849552]
10. Omoto K, Owen RM, Pryde DC, Watson CAL, Takeuchi M. (2014) Imidazopyridazine derivatives as GABAA receptor modulators.
Patent number: WO2014091368. Assignee: Pfizer Limited. Priority date: 14/12/2012. Publication date: 19/06/2014.
11. Pritchett DB, Lüddens H, Seeburg PH. (1989) Type I and type II GABAA-benzodiazepine receptors produced in transfected cells.
Science, 245 (4924): 1389-92.
[PMID:2551039]
12. Ramerstorfer J, Furtmüller R, Vogel E, Huck S, Sieghart W. (2010) The point mutation gamma 2F77I changes the potency and efficacy of benzodiazepine site ligands in different GABAA receptor subtypes.
Eur J Pharmacol, 636 (1-3): 18-27.
[PMID:20303942]
13. Sieghart W, Savić MM. (2018) International Union of Basic and Clinical Pharmacology. CVI: GABAA Receptor Subtype- and Function-selective Ligands: Key Issues in Translation to Humans.
Pharmacol Rev, 70 (4): 836-878.
[PMID:30275042]